针调节治疗信号通路的进展:一篇综述
Peiyao Meng1, Xuan Wang2, Wentao Yang1
1Graduate School, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang Province, China.
Medicine
|December 2, 2025
概括
对的针治疗调节关键的分子通路,减少神经炎症和氧化应激. 这项研究揭示了针.
科学领域:
- 神经科学是一个神经科学.
- 综合医学是一个整体的医学.
- 分子生物学分子生物学
背景情况:
- 是一种慢性神经系统疾病,其特点是经常性发作.
- 目前的抗药物通常具有有限的疗效和显著的副作用.
- 针已经显示出作为的辅助治疗的希望.
研究的目的:
- 在过去的二十年里,全面审查和分析全球关于针治疗的分子机制的研究.
- 阐明针治疗所针对的特定信号通路和细胞过程.
- 建立一个监管网络,连接针点,分子途径和管理中的治疗效果.
主要方法:
- 系统的文献综述和对调查针在中的分子机制的研究的元分析.
- 分析着重于特定针点 (如GV14,ST36) 的研究及其对信号通路的影响.
- 识别关键的分子标,包括PI3K/Akt,TLR4,NF-κB,mTOR,MAPK,BDNF/TrkB,以及Nrf2/ARE/HO-1. 这些标可以被测试.
主要成果:
- 针调节关键信号通路 (PI3K/Akt,TLR4,NF-κB,mTOR,MAPK,BDNF/TrkB,Nrf2/ARE/HO-1) 以产生抗作用. 这种疗法可以帮助治疗.
- 治疗机制包括抑制神经炎症,减轻氧化应激和抑制神经元亡.
- 针恢复了神经递质平衡和突触可塑性,恢复了中枢神经系统的兴奋/抑制平衡.
结论:
- 针通过一种多目标,多层次的管理方法来起作用.
- 一个"针点-通路效应"的监管网络是针疗效的基础.
- 这项研究强调了针作为治疗的有价值的治疗策略的潜力.
相关概念视频
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
01:24Epilepsy and Seizures: Overview
1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
791
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
791
01:14Antiepileptic Drugs: Glutamate Antagonists
863
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
863
01:20Antiepileptic Drugs: Potassium Channel Activators
611
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
611
01:17Antiepileptic Drugs: Calcium Channel Blockers
1.1K
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.1K